San Diego, CA -- (SBWIRE) -- 08/22/2017 -- An investor in NASDAQ:FMI shares filed a lawsuit against Foundation Medicine Inc over alleged Securities Laws violations by Foundation Medicine Inc in connection with certain allegedly false and misleading statements.

Investors who purchased shares of Foundation Medicine Inc (NASDAQ:FMI) have certain options and for certain investors are short and strict deadlines running. Deadline: September 26, 2017. NASDAQ:FMI investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

According to the complaint the plaintiff alleges on behalf of purchasers of Foundation Medicine Inc (NASDAQ:FMI) common shares between February 26, 2014 and November 3, 2015, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between February 26, 2014 and November 3, 2015, the defendants made false and/or misleading statements regarding the reimbursement process and likelihood of coverage for Foundation's tumor tests by Medicare and the Company's financial guidance.

Those who purchased shares of Foundation Medicine Inc (NASDAQ:FMI) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com